fluorobenzenes has been researched along with Asymptomatic Conditions in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glynn, RJ; Mora, S; Ridker, PM | 1 |
| Cai, J; Du, R; Gao, P; Leng, WX; Liu, DQ; Ma, L; Wang, QJ; Wu, HM; Ye, P; Zhao, XQ | 1 |
| Biacchi, D; Bononi, M; Borrelli, V; Di Marzo, L; Sapienza, P; Sterpetti, AV; Tartaglia, E; Venturini, L | 1 |
2 trial(s) available for fluorobenzenes and Asymptomatic Conditions
| Article | Year |
|---|---|
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy.
Topics: Aged; Angina, Unstable; Apolipoprotein A-I; Asymptomatic Diseases; Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Endpoint Determination; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Nuclear Magnetic Resonance, Biomolecular; Particle Size; Proportional Hazards Models; Pyrimidines; Risk; Rosuvastatin Calcium; Single-Blind Method; Stroke; Sulfonamides; Triglycerides | 2013 |
Early decrease in carotid plaque lipid content as assessed by magnetic resonance imaging during treatment of rosuvastatin.
Topics: Aged; Asymptomatic Diseases; Biomarkers; Carotid Artery Diseases; Carotid Artery, Common; China; Cholesterol, LDL; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2014 |
1 other study(ies) available for fluorobenzenes and Asymptomatic Conditions
| Article | Year |
|---|---|
Statins reduce levels of metalloproteinases in patients with carotid occlusive disease.
Topics: Aged; Angiography; Asymptomatic Diseases; Carotid Stenosis; Disease Progression; Drug Monitoring; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metalloproteases; Middle Aged; Plaque, Atherosclerotic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tissue Inhibitor of Metalloproteinases; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler, Color | 2014 |